The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Massively parallel assessment of human variants with base editor screens
Open accessPublished version of a preprint
Abstract
Understanding the functional consequences of single-nucleotide variants is critical to uncovering the genetic underpinnings of diseases, but technologies to characterize variants are limiting. Here, we leverage CRISPR-Cas9 cytosine base editors in pooled screens to scalably assay variants at endogenous loci in mammalian cells. We benchmark the performance of base editors in positive and negative selection screens, identifying known loss-of-function mutations in BRCA1 and BRCA2 with high precision. To demonstrate the utility of base editor screens to probe small molecule-protein interactions, we screen against BH3 mimetics and PARP inhibitors, identifying point mutations that confer drug sensitivity or resistance. We also create a library of single guide RNAs (sgRNAs) predicted to generate 52,034 ClinVar variants in 3,584 genes and conduct screens in the presence of cellular stressors, identifying loss-of-function variants in numerous DNA damage repair genes. We anticipate that this screening approach will be broadly useful to readily and scalably functionalize genetic variants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been utilized for several applications, including single point mutations and targeted mutation induction for therapeutic corrections of diseases (Musunuru et al., 2021), mutational screening, and gene knockout among the genomes (Hanna et al., 2021; Que et al., 2010).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Hanna et al., 2021
Citations
Cites
Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1131 · Cited by 17,749
The Ensembl Variant Effect Predictor
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R. S., Thormann, A., Flicek, P., & Cunningham, F. (2016) · Genome Biology · doi:10.1186/s13059-016-0974-4 · Cited by 8,099
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationImproved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637
ClinVar: improving access to variant interpretations and supporting evidence
Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Jang, W., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1153 · Cited by 4,196
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Self-citationNext-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
Cited by
Sorted by citations
Items 101–200 of 317
Kennedy, P. H., Sheikh, A. A. D., Balakar, M., Jones, A. C., Olive, M. E., Hegde, M., Matias, M. I., Pirete, N., Burt, R. A., Levy, J. M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02256-z · Cited by 30
CRISPR-dependent base editing as a therapeutic strategy for rare monogenic disorders
Cabré-Romans, J.-J., & Cuella-Martin, R. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1553590 · Cited by 33
Targeted manipulation of m6A RNA modification through CRISPR-Cas-based strategies
Sun, X., Wang, D. O., & Wang, J. (2022) · Methods · doi:10.1016/j.ymeth.2022.03.006 · Cited by 26
Liu, Y., Wang, R., Liu, J., Lu, H., Li, H., Wang, Y., Ni, X., Li, J., Guo, Y., Ma, H., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq2157 · Cited by 25
High-throughput screening of human genetic variants by pooled prime editing
Herger, M., Kajba, C. M., Buckley, M., Cunha, A., Strom, M., & Findlay, G. M. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100814 · Cited by 26
Integration of Organoids With CRISPR Screens: A Narrative Review
Mukhare, R., Gandhi, K., Kadam, A., Raja, A., Singh, A., Madhav, M., Chaubal, R., Pandey, S., & Gupta, S. (2025) · Biology of the Cell · doi:10.1111/boc.70006 · Cited by 26
Discovering new biology with drug-resistance alleles
Freedy, A. M., & Liau, B. B. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00865-9 · Cited by 25
Emerging technologies for prenatal diagnosis: The application of whole genome and RNA sequencing
Liu, P., & Vossaert, L. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6146 · Cited by 25
Genome-wide base editor screen identifies regulators of protein abundance in yeast
Schubert, O. T., Bloom, J. S., Sadhu, M. J., & Kruglyak, L. (2022) · eLife · doi:10.7554/elife.79525 · Cited by 21
Widespread epistasis among beneficial genetic variants revealed by high-throughput genome editing
Ang, R. M. L., Chen, S.-A. A., Kern, A., Xie, Y., & Fraser, H. B. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100260 · Cited by 23
Islam, M. M., Tamlander, M., Hlushchenko, I., Ripatti, S., & Pfisterer, S. G. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.10.006 · Cited by 21
Sahu, S., Sullivan, T. L., Mitrophanov, A. Y., Galloux, M., Nousome, D., Southon, E. A., Caylor, D., Mishra, A. P., Evans, C. N., Clapp, M. E., et al. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010940 · Cited by 24
An autoinhibitory switch of the LSD1 disordered region controls enhancer silencing
Waterbury, A. L., Kwok, H. S., Lee, C., Narducci, D. N., Freedy, A. M., Su, C., Raval, S., Reiter, A. H., Hawkins, W., Lee, K., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.05.017 · Cited by 22
Spahn, P. N., Zhang, X., Hu, Q., Lu, H., Hamaker, N. K., Hefzi, H., Li, S., Kuo, C., Huang, Y., Lee, J. C., et al. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.28016 · Cited by 22
A chemically controlled Cas9 switch enables temporal modulation of diverse effectors
Wei, C. T., Popp, N. A., Peleg, O., Powell, R. L., Borenstein, E., Maly, D. J., & Fowler, D. M. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01278-6 · Cited by 21
Functional profiling of serine, threonine and tyrosine sites
Li, Y., Xu, T., Ma, H., Yue, D., Lamao, Q., Liu, Y., Zhou, Z. L., & Wei, W. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01731-0 · Cited by 22
Mechanistic insights into genetic susceptibility to prostate cancer
Tian, P. W., Zhong, M., & Wei, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.025 · Cited by 22
Unbiased interrogation of functional lysine residues in human proteome
Bao, Y., Pan, Q., Xu, P., Liu, Z., Zhang, Z., Liu, Y., Xu, Y., Yu, Y., Zhou, Z. L., & Wei, W. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.10.033 · Cited by 19
CRISPR Technology and Its Emerging Applications
Zhang, X. E., Ma, D., & Liu, F. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf034 · Cited by 21
Cheng, W., Liu, F., Ren, Z., Chen, W., Chen, Y., Liu, T., Ma, Y., Cao, N., & Wang, J. (2022) · Nature Communications · doi:10.1038/s41467-022-28106-0 · Cited by 17
Functional Phosphoproteomics in Cancer Chemoresistance Using CRISPR‐Mediated Base Editors
Li, J., Lin, J., Huang, S., Li, M., Yu, W., Zhao, Y., Guo, J., Zhang, P., Huang, X., & Qiao, Y. (2022) · Advanced Science · doi:10.1002/advs.202200717 · Cited by 16
Emerging maps of allosteric regulation in cellular networks
Mathy, C. J. P., & Kortemme, T. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102602 · Cited by 20
Doll, R. M., Boutros, M., & Port, F. (2023) · Science Advances · doi:10.1126/sciadv.adj1568 · Cited by 18
Health research in the era of artificial intelligence: Advances in gene-editing study
Dai, M., Li, X., Zhang, Q., Liang, T., Huang, X., & Fu, Q. (2024) · Medicine Plus · doi:10.1016/j.medp.2024.100027 · Cited by 19
Robust and inducible genome editing via an all-in-one prime editor in human pluripotent stem cells
Wu, Y., Zhong, A., Sidharta, M., Kim, T. W., Ramirez, B., Persily, B., Studer, L., & Zhou, T. (2024) · Nature Communications · doi:10.1038/s41467-024-55104-1 · Cited by 22
A multiplex, prime editing framework for identifying drug resistance variants at scalePreprint
Chardon, F. M., Suiter, C. C., Daza, R. M., Smith, N. T., Parrish, P. C. R., McDiarmid, T. A., Lalanne, J., Martin, B., Calderon, D., Ellison, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.27.550902 · Cited by 17
Walsh, Z. H., Frangieh, C. J., Kothapalli, N., Levy, J. A., Heck, C., Melms, J. C., Gejman, R. S., Shah, P., Pollard, J. M., Naik, A., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.037 · Cited by 16
Zhang, H., McCarroll, A., Peyton, L., de León‐Guerrero, S. D., Zhang, S., Gowda, P., Sirkin, D., ElAchwah, M., Duhe, A., Wood, W., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.08.003 · Cited by 15
CRISPR base editing applications for identifying cancer-driving mutations
Pál, M., & Herold, M. J. (2021) · Biochemical Society Transactions · doi:10.1042/bst20200550 · Cited by 17
Prime editor-based high-throughput screening reveals functional synonymous mutations in human cells
Niu, X., Tang, W., Liu, Y., Mo, B., Liu, Y., Liu, Y., & Wei, W. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02710-z · Cited by 18
A streamlined base editor engineering strategy to reduce bystander editing
Valdez, I., O’Connor, I., Patel, D., Gierer, K., Harrington, J., Ellis, E., Caponetti, S. A., Sebra, R., Valley, H. C., Coote, K. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63609-6 · Cited by 17
Neuromuscular disorders: finding the missing genetic diagnoses
Koczwara, K. E., Lake, N. J., DeSimone, A. M., & Lek, M. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.07.001 · Cited by 16
Integrative dissection of gene regulatory elements at base resolution
Chen, Z., Javed, N. M., Moore, M. M., Wu, J., Sun, G., Vinyard, M. E., Collins, A., Pinello, L., Najm, F. J., & Bernstein, B. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100318 · Cited by 17
Manipulating and studying gene function in human pluripotent stem cell models
Balmas, E., Sozza, F., Bottini, S., Ratto, M. L., Savoré, G., Becca, S., Snijders, K. E., & Bertero, A. (2023) · FEBS Letters · doi:10.1002/1873-3468.14709 · Cited by 18
Functional annotation of variants of the BRCA2 gene via locally haploid human pluripotent stem cells
Li, H., Bartke, R., Zhao, L., Verma, Y., Horacek, A., Ben-Natan, A. R., Pangilinan, G. R., Krishnappa, N., Nielsen, R., & Hockemeyer, D. F. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01065-7 · Cited by 16
Development of a base editor for convenient and multiplex genome editing in cyanobacteria
Li, X.-D., Liu, L.-M., Xi, Y.-C., Sun, Q.-W., Luo, Z., Huang, H.-L., Wang, X.-W., Jiang, H.-B., & Chen, W. (2024) · Communications Biology · doi:10.1038/s42003-024-06696-3 · Cited by 14
Dziubańska-Kusibab, P. J., Nevedomskaya, E., & Haendler, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020705 · Cited by 14
Cooper, S., Coelho, M. A., Strauß, M. E., Gontarczyk, A. M., Wu, Q., Garnett, M. J., Marioni, J. C., & Bassett, A. R. (2024) · Genome biology · doi:10.1186/s13059-024-03169-y · Cited by 12
Understanding genetic variants in context
Sinnott-Armstrong, N., Fields, S., Roth, F. P., Starita, L. M., Trapnell, C., Villén, J., Fowler, D. M., & Queitsch, C. (2024) · eLife · doi:10.7554/elife.88231 · Cited by 14
CRISPR Screens to Identify Regulators of Tumor Immunity
LaFleur, M. W., & Sharpe, A. H. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-094725 · Cited by 16
Analyzing the functional effects of DNA variants with gene editing
Cooper, S., Obolenski, S., Waters, A. J., Bassett, A. R., & Coelho, M. A. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100776 · Cited by 14
Viswanatha, R., Entwisle, S., Hu, Y.-H., Kim, A.-R., Reap, K., Butnaru, M., Qadiri, M., Mohr, S. E., & Perrimon, N. (2025) · Nature Communications · doi:10.1038/s41467-025-61692-3 · Cited by 7
Deng, L., Zhou, Y., Cai, Z., Zhu, J., Li, Z., & Bao, Z. (2024) · Science Advances · doi:10.1126/sciadv.adj9382 · Cited by 16
Trans-eQTL hotspots shape complex traits by modulating cellular states
Renganaath, K., & Albert, F. W. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100873 · Cited by 11
Engineering of cytosine base editors with DNA damage minimization and editing scope diversification
Yuan, B., Zhang, S., Song, L., Chen, J., Cao, J., Qiu, Z., Qiu, Z., Chen, J., Zhao, X., & Cheng, T.-L. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad855 · Cited by 13
Potts, M. A., McDonald, J. A., Sutherland, K. D., & Herold, M. J. (2020) · European Journal of Immunology · doi:10.1002/eji.202048712 · Cited by 11
Pihlajamaa, P., Kauko, O., Sahu, B., Kivioja, T., & Taipale, J. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01444-6 · Cited by 11
CRISPR/Cas-Based Approaches to Study Schizophrenia and Other Neurodevelopmental Disorders
Kurishev, A. O., Karpov, D. S., Nadolinskaia, N. I., Гончаренко, А. В., & Голимбет, В. Е. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010241 · Cited by 13
Bcl-x short-isoform is essential for maintaining homeostasis of multiple tissues
Keller, M. A., Huang, C.-Y., Ivessa, A., Singh, S., Romanienko, P. J., & Nakamura, M. (2023) · iScience · doi:10.1016/j.isci.2023.106409 · Cited by 11
CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical Application
Bernard, B. E., Landmann, E., Jeker, L. T., & Schumann, K. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.03.005 · Cited by 12
Muhtaseb, A. W., & Duan, J. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.04.003 · Cited by 11
CRISPRmap: Sequencing-free optical pooled screens mapping multi-omic phenotypes in cells and tissue
Gu, J., Iyer, A., Wesley, B., Taglialatela, A., Leuzzi, G., Hangai, S., Decker, A., Gu, R., Klickstein, N., Shuai, Y., et al. (2023) · doi:10.1101/2023.12.26.572587 · Cited by 10
Deconstructing cancer with precision genome editing
Johnson, G. A., Gould, S. I., & Rivera, F. J. S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230984 · Cited by 11
Dorighi, K. M., Zhu, A., Fortin, J., Lo, J. H.-H., Sudhamsu, J., Wendorff, T. J., Durinck, S., Callow, M. G., Foster, S. A., & Haley, B. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114313 · Cited by 11
Wichroski, M. J., Liu, S.-Q., Zasadil, L. M., Benci, J. L., Gedeon, P. C., Condon, K. J., Joshi, S., Posy, S., Carlson, P., Maier, A., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0156 · Cited by 10
Evaluation and prediction of guide RNA activities in genome-editing tools
Kim, H. K., & Kim, S. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00352-z · Cited by 12
The Current Situation and Development Prospect of Whole-Genome Screening
Yang, C., Lei, Y., Ren, T., & Yao, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010658 · Cited by 12
CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discovery
Chiu, C. H. (2023) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2023.100127 · Cited by 10
High-throughput CRISPR technology: a novel horizon for solid organ transplantation
Li, X., Chen, Z., Ye, W., Yu, J., Zhang, X., Li, Y., Niu, Y., Ran, S., Wang, S., Luo, Z., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295523 · Cited by 10
Expanding the flexibility of base editing for high-throughput genetic screens in bacteria
Gawlitt, S., Collins, S. P., Yu, Y., Blackman, S. A., Barquist, L., & Beisel, C. L. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae174 · Cited by 9
CRISPR beyond: harnessing compact RNA-guided endonucleases for enhanced genome editing
Wang, F., Ma, S., Zhang, S., Ji, Q., & Hu, C. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2566-8 · Cited by 10
Activity-based selection for enhanced base editor mutational scanning
Kaplan, E. L., Steger, R. J., Shah, S. T., Drepanos, L. M., Griffith, A. L., Reint, G., & Doench, J. G. (2025) · Nature Genetics · doi:10.1038/s41588-025-02366-0 · Cited by 9
Towards a CRISPeR understanding of homologous recombination with high-throughput functional genomics
Hayward, S. B., & Ciccia, A. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.08.006 · Cited by 9
Efficient multitool/multiplex gene engineering with TALE-BE
Boyne, A. R., Yang, M., Pulicani, S., Feola, M., Tkach, D., Hong, R., Duclert, A., Duchateau, P. N., & Juillerat, A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1033669 · Cited by 9
Generation of PCBP1-deficient pigs using CRISPR/Cas9-mediated gene editing
Qi, C., Pang, D., Yang, K., Jiao, S., Wu, H., Zhao, C., Hu, L., Li, F., Zhou, J., Yang, L., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105268 · Cited by 9
Base Editor Scanning Reveals Activating Mutations of DNMT3A
Garcia, E. M., Lue, N. Z., Liang, J. K., Lieberman, W. K., Hwang, D. D., Woods, J. C., & Liau, B. B. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00257 · Cited by 9
Human genetics implicates a BACH2-NRF2 axis in fetal heamoglobin activationPreprint
Guo, C., Arora, U. P., Cheng, X., Xu, W., Cato, L. D., Li, R., Lu, H. Y., Lee, A., Yu, F., Agarwal, G., et al. (2023) · medRxiv · doi:10.1101/2023.03.24.23287659 · Cited by 9
Zhou, X., Gao, J., Luo, L., Huang, C., Wu, J., & Wang, X. (2024) · Communications Biology · doi:10.1038/s42003-024-07078-5 · Cited by 11
Chignon, A., & Lettre, G. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118621 · Cited by 9
Massively parallel interrogation of human functional variants modulating cancer immunosurveillance
Liu, Y., Liu, Y., Niu, X., Chen, A., Li, Y., Yu, Y., Mo, B., Liu, Z., Xu, T., Cheng, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02171-5 · Cited by 8
CRISPR-based genetic screens advance cancer immunology
Cao, Y., Li, X., Pan, Y., Wang, H., Yang, S., Hong, L., & Ye, L. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2571-0 · Cited by 8
The use of base editing technology to characterize single nucleotide variants
McDaniel, S., Komor, A. C., & Goren, A. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.03.031 · Cited by 7
CRISPR-based genome editing in disease treatment
Qin, H., Xu, W., & Yao, K. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.05.003 · Cited by 8
Massively parallel approaches for characterizing noncoding functional variation in human evolution
Rong, S., Root, E., & Reilly, S. K. (2024) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102256 · Cited by 9
High-throughput screening for optimizing adoptive T cell therapies
Zhang, Y., Xu, Q., Gao, Z., Zhang, H., Xie, X., & Li, M. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00580-w · Cited by 8
Strategies and mechanisms of precision genome engineering: From gene editing to genome writing
Huang, K., Tian, J., Zhao, W., Zhang, S., Xiang, L., Yang, M., Ls, L., Huang, Y., Zhang, N., Sun, L., et al. (2026) · iMetaOmics. · doi:10.1002/imo2.70115 · Cited by 8
Towards elucidating disease-relevant states of neurons and glia by CRISPR-based functional genomics
Leng, K., & Kampmann, M. (2022) · Genome Medicine · doi:10.1186/s13073-022-01134-7 · Cited by 7
Decoding molecular mechanisms for loss-of-function variants in the human proteomePreprint
Cagiada, M., Jonsson, N., & Lindorff‐Larsen, K. (2025) · eLife · doi:10.7554/elife.108160.1 · Cited by 9
Genome editing with programmable base editors in human cells
Osgood, N. R. B., Zawalick, N. M., Sawyer, C. B., Cowan, Q. T., Gu, S., Mawson, S. J., Ranzau, B. L., Li, L., Gymrek, M., Goren, A., et al. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.01.001 · Cited by 6
Sokirniy, I., Inam, H., Tomaszkiewicz, M., Reynolds, J., McCandlish, D. M., & Pritchard, J. R. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf738 · Cited by 6
RNA-coupled CRISPR screens reveal ZNF207 as a regulator of LMNA aberrant splicing in progeria
Behera, A. K., Kim, J. J., Kordale, S., Pekovic, F., Damodaran, A. P., Kumari, B., Vidak, S., Dickson, E., Xiao, M.-S., Duncan, G., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2025.12.003 · Cited by 6
Triple base editor catalyzes saturation mutation of adenine, cytidine, and guanine
Wu, Y., Wang, J., Zhang, Z., Shang, M., Wang, S. W., Li, Y., Li, G., lu, S., Ji, K., Wang, X., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf1423 · Cited by 6
A proteome-wide dependency map of protein interaction motifs
Ambjørn, S. M., Meeusen, B., Kliche, J., Wang, J., Garvanska, D. H., Kruse, T., Mendez, B. L., Mann, M., Mailand, N., Hertz, E. P. T., et al. (2026) · Nature Structural & Molecular Biology · doi:10.1038/s41594-026-01762-2 · Cited by 8
Single-cell and spatial profiling in cancer biology and clinical oncology
Frangieh, C. J., Fan, J. L., Melms, J. C., Shah, P., Azizi, E., & Izar, B. (2026) · Nature Cancer · doi:10.1038/s43018-026-01142-1 · Cited by 8
Large-Scale CRISPR Screen of LDLR Pathogenic Variants
Li, M., Ma, L., Chen, Y., Li, J., Wang, Y., You, W., Yuan, H., Tang, X., Ouyang, H., & Pang, D. (2023) · Research · doi:10.34133/research.0203 · Cited by 6
Yao, Y., Zhou, Z., Wang, X., Liu, Z., Zhai, Y., Chi, X., Du, J., Luo, L., Zhao, Z., Wang, X., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100583 · Cited by 6
Ma, L., Xing, J., Li, Q., Zhang, Z., & Xu, K. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102103 · Cited by 6
CRISPR‐Suppressor Scanning for Systematic Discovery of Drug‐Resistance Mutations
Ngan, K. C.-H., Lue, N. Z., Lee, C., & Liau, B. B. (2022) · Current Protocols · doi:10.1002/cpz1.614 · Cited by 7
CRISPR-Mediated Base Editing: Promises and Challenges for a Viable Oncotherapy Strategy
Huang, L., Yang, C., Chen, Y., Deng, H., Liao, Z., & Xiao, H. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.045 · Cited by 7
CRISPR base editor screens identify variant function at scale
Parrish, P. C. R., & Berger, A. H. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.036 · Cited by 6
Tools for Decoding Ubiquitin Signaling in DNA Repair
Foster, B., Attwood, M., & Gibbs‐Seymour, I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760226 · Cited by 5
Wilson, J., & Loizou, J. I. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13272 · Cited by 6
Dual guide RNA-mediated concurrent C&G-to-T&A and A&T-to-G&C conversions using CRISPR base editors
Zhao, Y., Li, M., Liu, J., Xue, X., Zhong, J., Lin, J., Ye, B., Chen, J., & Qiao, Y. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.055 · Cited by 6
TDP1 splice-site mutation causes HAP1 cell hypersensitivity to topoisomerase I inhibition
Goh, C. G., Bader, A. S., Tran, T.-A., Belotserkovskaya, R., D’Alessandro, G., & Jackson, S. P. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae1163 · Cited by 5
Yuan, L., Ji, W., Dwyer, B. G., Lu, J., Bian, J. T., Colombo, G. M., Martinez, M. J., Fernández, D., Phillips, N. A., Tang, M. T., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0271 · Cited by 6
Jung, Y. J., Yu, G., Oh, H.-C., Lee, J.-H., Jeon, E., Bae, J., Sim, T., & Kim, S. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01531-4 · Cited by 7
Precision genome editing with DNA base editors
Mawson, S. J., Dunne-Dombrink, K., Pollak, B. R., & Komor, A. C. (2026) · Nature Reviews Methods Primers · doi:10.1038/s43586-026-00478-3 · Cited by 8
Drug screening approaches for small-molecule compounds in cancer-targeted therapy
Zhao, Y., Yuan, C., Shi, Y., Liu, X., Luo, L., Zhang, L., Pešić, M., Yao, H.-J., & Li, L. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2427185 · Cited by 5
Vasquez, C. A., Osgood, N. R. B., Zepeda, M. L., Sandel, D. K., Cowan, Q. T., Peiris, M. N., Donoghue, D. J., & Komor, A. C. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf037 · Cited by 7
Metadata
- Authors
- Hanna, R. E., Hegde, M., Fagre, C. R., DeWeirdt, P. C., Sangree, A. K., Szegletes, Z., Griffith, A., Feeley, M. N., Sanson, K. R., Baidi, Y., Koblan, L. W., Liu, D. R., Neal, J. T., & Doench, J. G.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Doench, John G.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 184
- Issue
- 4
- Pages
- 1064-1080.e20
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3132864675
- Cited by
- 316
- References
- 81
- Citations by year
- 2026: 41 · 2025: 65 · 2024: 57 · 2023: 62 · 2022: 57 · 2021: 29
- FWCI
- 16.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 382 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Science Foundation
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- single nucleotide variants, loss-of-function mutations, BRCA1, BRCA2, BH3 mimetics, PARP inhibitors, drug resistance, drug sensitivity, DNA repair genes, cellular stress, single guide RNA library, ClinVar variants
- MeSH terms
- Gene Editing, Loss of Function Mutation, Alleles, Base Sequence, Humans, Poly(ADP-ribose) Polymerases, Selection, Genetic, Genetic Variation, Reproducibility of Results, Mutagenesis, Point Mutation, BRCA1 Protein, Catalytic Domain, BRCA2 Protein, Cell Line, Tumor, bcl-X Protein, High-Throughput Nucleotide Sequencing, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review